Frequently asked questions.

Cereus offers investment opportunities exclusively to accredited investors. Under SEC guidelines, that generally means individual income above $200,000 (or $300,000 joint income with a spouse) in each of the last two years, or net worth above $1 million excluding your primary residence. If you're not sure whether you qualify, join the investor list — the qualification process will help clarify it.

$50,000 for most offerings. The exact minimum can vary by deal and is always stated clearly in that offering's private placement memorandum before you commit any capital.

No. Joining is free and simply gives you access to review offerings as they open — there's no obligation to invest in any specific deal.

Complete the short investor qualification survey — you'll find "Join the Investor List" throughout the site. Once you're in the network, you'll be notified as new offerings become available for review.

Cereus is deal-by-deal, not a blind-pool fund. Each offering is a separate syndication built around one specific property, so you always know exactly what you're investing in before you commit — the actual asset, business plan, and numbers for that deal, not a discretionary pool you can't see into.

Every offering passes through the same four-stage review before it ever reaches the investor list — sponsor, market, capital structure, and business plan. Most opportunities that cross our desk never clear all four. See our full approach →

In most cases, Cereus takes a limited partner position on behalf of individual investors, investing alongside a proven third-party sponsor. When Cereus is planning to take a general partner position instead, that will be clearly delineated in the offering materials.

Our goal is to offer investors a diversity of opportunities across real estate, with a specialization in multifamily. That's meant primarily workforce and multifamily value-add to date, alongside select ground-up development and medical office opportunities. See the current portfolio →

Generally 3–5 years for value-add multifamily, around 3 years for ground-up development, and 3–5 years for medical office rollups. The target hold is always stated in each offering's materials.

Distribution frequency ranges from monthly to quarterly depending on the operator and sponsor for that specific offering, once the property is stabilized. Exact timing and amount depend on that deal's business plan and are never guaranteed.

You should generally plan to file a tax extension in any year you're invested in a deal. Because your K-1 reflects tax information collected and processed from multiple underlying sponsors to form the unified fund K-1, it typically isn't ready in time for the standard filing deadline. Your CPA can plan around this in advance — extensions are routine for real estate partnerships.

Yes. Cereus works with Equity Trust for investors who want to use retirement funds, and can help walk you through the process.

Fees vary by offering and are always fully disclosed in that deal's disclosure documents before you invest. There's never a fee to join the investor list or review an offering.

No. These are private real estate investments, and your capital is generally committed for the duration of the hold period. There's no established secondary market to sell your position early.

Every business plan is pressure-tested against a downside case before it ever reaches the investor list — but real estate investing carries real risk, including loss of principal, and past performance is never a guarantee of future results.

Generally, no. Outside of unusual circumstances negotiated directly with the sponsor, your capital is committed for the target hold period stated in the offering.

Founder Daniel Shin, MD built his own real estate portfolio before ever raising outside capital, after experiencing firsthand the toll of relying solely on clinical income. Cereus exists to give other high-earning professionals the same path to passive wealth — without a second job.

Yes. Daniel invests his own capital in every deal Cereus offers.